# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
SuRo Capital (NASDAQ:SSSS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12...
Barrington Research analyst Alexander Paris maintains SuRo Capital (NASDAQ:SSSS) with a Outperform and maintains $6 price ta...
SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS...
JMP Securities analyst Devin Ryan maintains SuRo Capital (NASDAQ:SSSS) with a Market Outperform and raises the price target ...
Barrington Research analyst Alexander Paris maintains SuRo Capital (NASDAQ:SSSS) with a Outperform and maintains $6 price ta...
SuRo Capital (NASDAQ:SSSS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) ...
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...
Liquid Death is raising more money to help consumers murder their thirst. Here's a look at the new investors, including sev...